Pfizer Settles B.Y.U. Lawsuit Over Development of Celebrex
Read this article hotklixed More than a Year Ago! Pfizer said in a regulatory filing with the Securities and Exchange Commission that it was taking a $450 million charge against first-quarter earnings to settle the case.
By shradha | More than a Year Ago